Colossal CEO links de-extinction work to human longevity
CNBC · RSS · · AI-summarised by FinFlash
Colossal Biosciences CEO Ben Lamm says the company's work to bring back extinct species such as dire wolves and woolly mammoths can contribute to conservation, healthcare and developmental biology. The company frames de-extinction as a platform whose genetic tools may have broader medical applications, including research relevant to extending human life.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.